In a new video to mark Bladder Cancer Awareness Month, which is observed in May each year, Dr Florence Le Calvez-Kelm and Dr Mahdi Sheikh of the Genomic Epidemiology Branch at the International Agency for Research on Cancer (IARC) present their research on biomarkers that could act as an early detection method for bladder cancer, potentially offering a tool to cost-effectively screen individuals at high risk of developing the disease.
Every year, more than 500 000 people worldwide are diagnosed with bladder cancer. It is a complex and highly recurrent disease, and one of the most challenging and most expensive cancer types to diagnose and treat.
This new video offers an insight into IARC’s laboratories and the important research being carried out there. It also highlights the international aspect of the Agency’s work in planning studies and collaborating with partners across the globe. The urine biomarker discussed in the video showed promising results as a simple, non-invasive test to detect bladder cancer at early stages of development, potentially leading to improvements in the clinical management of bladder cancer and in screening of high-risk populations, such as smokers or workers exposed to bladder carcinogens.